These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16315873)

  • 21. Metastatic melanoma of the common bile duct and ampulla of Vater.
    van Bokhoven MM; Aarntzen EH; Tan AC
    Gastrointest Endosc; 2006 May; 63(6):873-4. PubMed ID: 16650564
    [No Abstract]   [Full Text] [Related]  

  • 22. Melanoma and lymphoma rejection associated with eosinophil infiltration upon intratumoral injection of dendritic and NK/LAK cells.
    Capobianco A; Manfredi AA; Monno A; Rovere-Querini P; Rugarli C
    J Immunother; 2008 Jun; 31(5):458-65. PubMed ID: 18463539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
    Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
    J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.
    Shu S; Cochran AJ; Huang RR; Morton DL; Maecker HT
    Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients.
    Verdijk P; Aarntzen EH; Lesterhuis WJ; Boullart AC; Kok E; van Rossum MM; Strijk S; Eijckeler F; Bonenkamp JJ; Jacobs JF; Blokx W; Vankrieken JH; Joosten I; Boerman OC; Oyen WJ; Adema G; Punt CJ; Figdor CG; de Vries IJ
    Clin Cancer Res; 2009 Apr; 15(7):2531-40. PubMed ID: 19318472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining conventional therapies with intratumoral injection of autologous dendritic cells and activated T cells to treat patients with advanced cancers.
    Mann DL; Celluzzi CM; Hankey KG; Harris KM; Watanabe R; Hasumi K
    Ann N Y Acad Sci; 2009 Sep; 1174():41-50. PubMed ID: 19769735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radical resection in signet ring carcinoma of the ampulla of Vater: report of an 11-year survivor.
    Bloomston M; Walker M; Frankel WL
    Am Surg; 2006 Feb; 72(2):193-5. PubMed ID: 16536256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunologic and clinical effects of injecting mature peptide-loaded dendritic cells by intralymphatic and intranodal routes in metastatic melanoma patients.
    Lesimple T; Neidhard EM; Vignard V; Lefeuvre C; Adamski H; Labarrière N; Carsin A; Monnier D; Collet B; Clapisson G; Birebent B; Philip I; Toujas L; Chokri M; Quillien V
    Clin Cancer Res; 2006 Dec; 12(24):7380-8. PubMed ID: 17189411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of an effective method for dendritic cell immunotherapy of mouse melanoma.
    Lee TH; Cho HK; Cho YH; Lee MG
    Scand J Immunol; 2009 Aug; 70(2):85-92. PubMed ID: 19630913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
    Nakamura M; Wada J; Suzuki H; Tanaka M; Katano M; Morisaki T
    Anticancer Res; 2009 Mar; 29(3):831-6. PubMed ID: 19414316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A possibility of overcoming local tumor immune tolerance by radiofrequency ablation in combination with intratumoral injection of naïve dendritic cell].
    Saji H; Song W; Nakamura H; Saijo T; Hosaka M; Hagiwara M; Ogata A; Kawasaki N; Engleman EG; Kato H
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1736-8. PubMed ID: 17212091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granulomatous hepatitis caused by B.C.G. injection during immunotherapy of a malignant melanoma.
    Serrou B; Michel H; Dubois JB; Serre A
    Biomedicine; 1975 Jun; 23(6):236-40. PubMed ID: 764894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy against metastatic renal cell carcinoma with mature dendritic cells.
    Matsumoto A; Haraguchi K; Takahashi T; Azuma T; Kanda Y; Tomita K; Kurokawa M; Ogawa S; Takahashi K; Chiba S; Kitamura T
    Int J Urol; 2007 Apr; 14(4):277-83. PubMed ID: 17470153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in ampulla of vater adenocarcinoma: comparison between expression patterns and histologic subtypes.
    Sanada Y; Yoshida K; Konishi K; Oeda M; Ohara M; Tsutani Y
    Oncol Rep; 2006 May; 15(5):1157-61. PubMed ID: 16596179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis.
    Roh YH; Kim YH; Lee HW; Kim SJ; Roh MS; Jeong JS; Jung GJ
    Hepatogastroenterology; 2007 Sep; 54(78):1641-4. PubMed ID: 18019683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of early depressed-type ampullary carcinoma treated by wire-guided endoscopic resection.
    Katsinelos P; Kountouras J; Chatzimavroudis G; Zavos C; Paroutoglou G; Kotakidou R; Panagiotopoulou K; Papaziogas B
    Surg Laparosc Endosc Percutan Tech; 2007 Dec; 17(6):533-7. PubMed ID: 18097317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolated tuberculosis of the ampulla of vater masquerading as periampullary carcinoma: a case report.
    Tewari M; Mishra RR; Kumar V; Kar AG; Shukla HS
    JOP; 2009 Mar; 10(2):184-6. PubMed ID: 19287114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase-I trial using a universal GM-CSF-producing and CD40L-expressing bystander cell line (GM.CD40L) in the formulation of autologous tumor cell-based vaccines for cancer patients with stage IV disease.
    Dessureault S; Noyes D; Lee D; Dunn M; Janssen W; Cantor A; Sotomayor E; Messina J; Antonia SJ
    Ann Surg Oncol; 2007 Feb; 14(2):869-84. PubMed ID: 17103257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
    Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colony-stimulating factor or interleukin-2: the transgene determines the composition of the inflammatory infiltrate.
    Hofbauer GF; Baur T; Bonnet MC; Tartour E; Burg G; Berinstein NL; Dummer R
    Melanoma Res; 2008 Apr; 18(2):104-11. PubMed ID: 18337646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.